Insider Trading History of Ware J. Anthony

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ware J. Anthony since 2020. This trader's CIK number is 1715429. At the time of last reporting, Ware J. Anthony was the Officer of First Tracks Biotherapeutics, Inc.. (stock ticker symbol TRAX). Also see all insider trading activities at First Tracks Biotherapeutics, Inc..

Note that in the past Ware J. Anthony also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Anaptysbio, Inc (ANAB) by Ware J. Anthony

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ANAB 0 $0 3,900 $193,342 6,030 $0
2024 ANAB 0 $0 0 $0 3,900 $0
2019 ANAB 3,600 $50,580 0 $0 0 $0

Yearly summary of insider trading at First Tracks Biotherapeutics, Inc. (TRAX) by Ware J. Anthony

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 TRAX 0 $0 0 $0 6,030 $0


Insider trading activities at 2 companies by Ware J. Anthony:

1. Anaptysbio, Inc (ANAB)

2. First Tracks Biotherapeutics, Inc. (TRAX)

Table 1. Insider trading of Anaptysbio, Inc (ANAB) by Ware J. Anthony

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-12-23 ANAB Sale 3,900 49.58 193,342
2025-06-15 ANAB Option Ex 6,030 .00 0
2024-06-15 ANAB Option Ex 3,900 .00 0
2019-12-10 ANAB Buy 3,600 14.05 50,580

Table 2. Insider trading of First Tracks Biotherapeutics, Inc. (TRAX) by Ware J. Anthony

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-06-15 TRAX Option Ex 6,030 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ware J. Anthony (Officer of First Tracks Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.